Toronto, Ontario--(Newsfile Corp. - July 22, 2021) - Microdose Psychedelic Insights is proud to announce the upcoming Psychedelic Capital: July 2021 conference to be taking place on July 29, 2021. The July edition will tackle Drug Delivery and Supply Chain in the Psychedelic Medicine Industry. Click here to get a free ticket: https://microdose.buzz/pressrelease
The virtual event will seek to provide attendees with some of the top companies, latest IPOs, newest opportunities, and deepest industry insights within the sector.
Part of an investor conference series diving deep into psychedelic medicine investment, Psychedelic Capital conferences seek to introduce investors and attendees with a curated group of CEOs, capital advisors, and investment luminaries from around the world.
The conference will subsequently play host to a number of corporate presentations, including: Levitee Labs, Mycrodose Therapeutics and Entheo Digital.
"The PsyCap audience knows the growing global burden of mental health, addiction, and chronic pain needs to be addressed. I'm looking forward to diving into the active steps Levitee Labs is taking to be at the forefront of addressing the root of this issue and how we are already highly differentiated from other companies in the psychedelic market. A key focus will be the story behind how we're transforming the traditional treatment landscape through our cash-flowing integrative wellness platform." - Pouya Farmand, CEO Levitee Labs
"The Mycrodose Therapeutics team is thrilled to be part of the July 2021 Psychedelic Capital Event. We are looking forward to sharing with a larger audience the story of our rapid expansion since our inception in 2020, discussing details of our novel technologies and milestones, and why we chose to focus on Advanced Drug Delivery Technologies as our core business model.' - Patrick Eckstrom, President, Mycrodose Therapeutics
The conference will seek to enable attendees to build relationships, network with professionals from across the psychedelics industry, and gain access to exciting and ground-breaking pre-IPO investment opportunities within the wider sector.
Additional information about the Psychedelic Capital: July 2021 conference, as well as details for registration, can be found here: https://microdose.buzz/pressrelease
### Ends ###
Notes to Editors
To request media accreditation, or to arrange interviews with key personnel please contact:
Kristina Spionjak
kristina@microdose.buzz
About Microdose Psychedelic Insights
Microdose Psychedelic Insights aims to unlock the potential of psychedelics through Industry events, market intelligence, original, evidence-based content, strategy and community. We enable and empower society at large to make better, more mindful decisions about psychedelics and its intersection with healthcare, medicine and personal growth. We work with the industry's most influential stakeholders, some of the world's best-known brands and an unrivalled network of scientists, researchers, analysts, innovators, investors and advisors.
About PsyCap
This online event programming is dedicated to providing investment grade information for the nascent psychedelic sector and presents a curated group of CEOs, financial experts, thought leaders and investment luminaries from around the globe. Presentations are 30 minutes in length, with 10 minutes always allocated to a one-on-one Q&A session with the audience. Psychedelic Capital features the top companies, latest IPOs, newest opportunities and deepest insights into the emerging psychedelic space.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/90793
